| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| |||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on January 7, 2009
Accepted on May 4, 2009
University of Geneva, Department of Genetic Medicine and Development, University Medical Center, Geneva, Switzerland; Cell Isolation and Transplantation Center, Division of Surgical Research, Department of Surgery, University Hospital, Geneva, Switzerland; and Division of Endocrinology and Diabetes, University Hospital, Zurich, Switzerland
* To whom correspondence should be addressed. E-mail: geraldine.parnaud{at}.unige.ch.
Laminin-5-rich extracellular matrix derived from 804G cells (804G-ECM) induces spreading, improves glucose-stimulated insulin secretion, and increases survival and proliferation of rat pancreatic beta-cells. The aim of the study was to determine growth signaling pathways activated by ECM with a particular focus on Ca2+-dependent transcription factors. 804G-ECM increased rat beta-cell proliferation and this stimulation was glucose- and Ca2+-dependent. NF-
B nuclear translocation as well as IkB
gene expression were also Ca2+-dependent. Inhibition of NF-
B almost completely blocked 804G-ECM-stimulated beta-cell proliferation as did the soluble IL-1 receptor antagonist IL-1Ra. 804G-ECM-induced proliferation was also blocked by cyclosporin A and the VIVIT peptide suggesting involvement of NFAT/calcineurin. Use of selective inhibitors further implicated other pathways in this process. Inhibition of PI3 kinase and protein kinase A both prevented beta-cell replication stimulated by 804G-ECM. Conversely, inhibition of MAPK, JNK, p38 and GSK3
increased beta-cell proliferation on 804G-ECM. Our results suggest that Ca2+ entry which is necessary for increased beta-cell proliferation on 804G-ECM is also involved in 804G-ECM induced NF-
B activity. It is proposed that increased cytosolic Ca2+ leads to activation of the transcription factors NFAT and NF-
B that in turn increase beta-cell proliferation. Activation of PI3 kinase by 804G-ECM also increases proliferation possibly by synergistic co-activation of NFAT via inhibition of GSK3
, while IL-1
may amplify the process by feed-forward activation of NF-
B. Conversely, inhibition of the MAPK pathway increased beta-cell proliferation indicating a counter-regulatory restraining role for this signaling pathway.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |